Chargement en cours...
MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells
Osteosarcoma (OS) is the most common cancer of the bone. Chemotherapy is commonly used for the clinical treatment of OS. However, chemoresistance to cisplatin [also known as diamminedichloridoplatinum (II) (DDP)] is a major obstacle for OS therapy, the underlying mechanism of which is not fully unde...
Enregistré dans:
| Publié dans: | Oncol Lett |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5104258/ https://ncbi.nlm.nih.gov/pubmed/27895792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5172 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|